•
Sep 30, 2016

Outlook Therapeutics Q4 2016 Earnings Report

Total Revenue
$495K
Previous year: $495K
+0.0%
EPS
-$4.8
Previous year: -$183
-97.4%
Gross Profit
$0
0
Cash and Equivalents
$2.35M
Total Assets
$25.4M

Outlook Therapeutics

Outlook Therapeutics